Reliability of self-reported family history of cancer in a large case-control study of lymphoma
- PMID: 16391372
- DOI: 10.1093/jnci/djj005
Reliability of self-reported family history of cancer in a large case-control study of lymphoma
Abstract
Background: Case-control studies of familial cancer risk traditionally rely on self-reported family history of cancer, which may bias results due to differential recall between case patients and control subjects. To evaluate the reliability of self-reported data, we analyzed questionnaire and registry-based data on familial cancer from a population-based case-control study of malignant lymphoma.
Methods: All 1508 lymphoma case patients and 1229 control subjects completed a telephone interview assessing cancer in family members. Participants were linked to the Swedish Multi-Generation Register and Cancer Register to identify confirmed cancer diagnoses in first-degree relatives. The sensitivity and specificity of self-reported familial cancer were calculated among case patients and control subjects and were compared using logistic regression. All statistical tests were two-sided.
Results: Lymphoma case patients reported a family history of any cancer with statistically significantly higher sensitivity than control subjects (0.85, 95% confidence interval [CI] = 0.83 to 0.87 and 0.80, 95% CI = 0.77 to 0.82, respectively) but with marginally lower specificity (0.89, 95% CI = 0.87 to 0.91 and 0.92, 95% CI = 0.90 to 0.94, respectively). The sensitivity of self-reporting familial cancers by site ranged from less than 0.20 for rare malignancies to nearly 0.75 for more common types, whereas specificity was generally 0.98 or greater. For most sites, the reliability of self-report was similar in patients and control subjects. However, patients reported familial hematopoietic cancer with statistically significantly higher sensitivity (0.60, 95% CI = 0.57 to 0.62) than control subjects (0.38, 95% CI = 0.35 to 0.40). Odds ratios for the association between familial cancer and risk of non-Hodgkin lymphoma were consistently higher when based on self-reported, compared with registry data-based, family history of any cancer or of hematopoietic cancer.
Conclusions: Reliability of self-reported family history of cancer varies between case patients and control subjects. Recall bias may thus produce biased results in case-control studies of familial cancer risk.
Similar articles
-
Family history of hematopoietic malignancy and risk of lymphoma.J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293. J Natl Cancer Inst. 2005. PMID: 16204696
-
Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer.Cancer Causes Control. 2008 Jun;19(5):469-79. doi: 10.1007/s10552-007-9108-3. Epub 2008 Jan 16. Cancer Causes Control. 2008. PMID: 18197461
-
Family history of hematopoietic and non-hematopoietic malignancies and risk of non-Hodgkin lymphoma.Cancer Causes Control. 2007 May;18(4):351-9. doi: 10.1007/s10552-006-0088-5. Epub 2007 Jan 6. Cancer Causes Control. 2007. PMID: 17206533
-
The prevalence of familial testicular cancer: an analysis of two patient populations and a review of the literature.Cancer. 1997 Nov 15;80(10):1954-60. Cancer. 1997. PMID: 9366298 Review.
-
Effects of misclassification on estimates of relative risk in family history studies.Genet Epidemiol. 1999;16(4):368-81. doi: 10.1002/(SICI)1098-2272(1999)16:4<368::AID-GEPI4>3.0.CO;2-A. Genet Epidemiol. 1999. PMID: 10207718 Review.
Cited by
-
Family history of cancer and risk of pediatric and adolescent Hodgkin lymphoma: A Children's Oncology Group study.Int J Cancer. 2015 Nov 1;137(9):2163-74. doi: 10.1002/ijc.29589. Epub 2015 May 19. Int J Cancer. 2015. PMID: 25940226 Free PMC article.
-
Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry.Breast Cancer Res Treat. 2009 Sep;117(1):167-76. doi: 10.1007/s10549-008-0255-3. Epub 2008 Nov 26. Breast Cancer Res Treat. 2009. PMID: 19034644 Free PMC article.
-
Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium.Eur J Cancer. 2012 Sep;48(13):1957-68. doi: 10.1016/j.ejca.2012.01.038. Epub 2012 Mar 19. Eur J Cancer. 2012. PMID: 22436981 Free PMC article.
-
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung).J Transl Med. 2024 Jul 31;22(1):714. doi: 10.1186/s12967-024-05538-4. J Transl Med. 2024. PMID: 39085889 Free PMC article.
-
Risk of hematological malignancies in the families of patients treated for nodular lymphocyte-predominant Hodgkin lymphoma.Hered Cancer Clin Pract. 2021 Feb 9;19(1):17. doi: 10.1186/s13053-021-00175-0. Hered Cancer Clin Pract. 2021. PMID: 33563316 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical